Asset Allocation

As of November 30, 2025.
Type % Net
Cash 3.52%
Stock 96.06%
Bond 0.00%
Convertible 0.00%
Preferred 0.00%
Other 0.41%
View Asset Allocation
Start Trial

Market Capitalization

As of November 30, 2025
Large 76.49%
Mid 17.94%
Small 5.57%
View Market Capitalization
Start Trial

Region Exposure

% Developed Markets: 99.54%    % Emerging Markets: 0.04%    % Unidentified Markets: 0.41%

Americas 76.51%
75.22%
Canada 9.61%
United States 65.61%
1.29%
As of November 30, 2025. Region breakdown data is calculated by using the long position holdings of the portfolio.
Greater Europe 13.19%
United Kingdom 6.00%
6.77%
Austria 0.38%
Denmark 0.03%
France 0.70%
Germany 1.50%
Ireland 0.78%
Italy 0.27%
Netherlands 0.13%
Spain 1.25%
Sweden 0.20%
Switzerland 1.05%
0.00%
0.42%
Israel 0.42%
Greater Asia 9.88%
Japan 5.85%
2.26%
Australia 2.08%
1.77%
Hong Kong 0.30%
Singapore 0.94%
South Korea 0.26%
0.00%
Unidentified Region 0.41%

Stock Sector Exposure

Cyclical
30.86%
Materials
3.70%
Consumer Discretionary
11.38%
Financials
15.60%
Real Estate
0.18%
Sensitive
53.83%
Communication Services
10.55%
Energy
1.84%
Industrials
12.28%
Information Technology
29.16%
Defensive
15.24%
Consumer Staples
4.38%
Health Care
9.80%
Utilities
1.07%
Not Classified
0.07%
Non Classified Equity
0.07%
Not Classified - Non Equity
0.00%
As of November 30, 2025
View Region Exposure
Start Trial

Stock Style Exposure

Large Cap Value --
Large Cap Core --
Large Cap Growth --
Mid Cap Value --
Mid Cap Core --
Mid Cap Growth --
Small Cap Value --
Small Cap Core --
Small Cap Growth --
No Data Available